Dr. Sandeep Arora is the President (R&D) at Natural Solutions & Nutraceuticals Pvt. Ltd. and a Director at Amity University, Noida. With a robust academic background and extensive experience in research and development, Dr. Arora significantly contributes to the nutraceuticals industry. At Natural Solutions & Nutraceuticals Pvt. Ltd., he spearheads innovative projects focused on developing natural health solutions, emphasizing herbal and organic ingredients. Simultaneously, his leadership at Amity University fosters a research-driven environment, promotes interdisciplinary studies, and enhances the institution’s global academic reputation. Dr. Arora’s work reflects a commitment to sustainable development and the advancement of health sciences. Recognized as a visionary leader, he effectively integrates scientific research with practical applications, earning him prominence in both academic and industrial circles.
In an exclusive exchange with The Interview World, Dr. Sandeep Arora illuminates recent innovations in Ayush products. He shares insights into how cosmetic and nutraceutical companies are harnessing innovation to develop new products. Dr. Arora also emphasizes the efficacy of Ayurvedic products in treating critical illnesses. Here are the pivotal insights from his interview.
Q: How are Ayush companies advancing innovation within the country?
A: Ayush companies like Hamdard and Dabur are significantly advancing their R&D activities to develop innovative products. They focus on validating therapeutic claims by providing substantial evidence through rigorous preclinical animal experimentation and subsequent clinical trials. Furthermore, they are enhancing the quality profile of their Ayurvedic products by meticulously identifying and quantifying the chemical compounds in herbs, ensuring a comprehensive and transparent reporting process. These concerted efforts are not only bolstering the credibility of their therapeutic claims but also driving substantial improvements in the overall quality and efficacy of their product offerings, reinforcing their positions as industry leaders.
Q: Are cosmetic and nutraceutical companies also adopting this trend?
A: In the cosmetics and nutraceuticals sectors, many new products are emerging that offer superior finish due to advanced technology. For instance, incorporating nanotechnology, microparticles, and nanoparticles significantly enhances the smoothness of creams, lotions, and oral formulations. This technological advancement improves the texture and enhances targeting, overall efficacy, and viability.
Previously, a product might have had only 30% bioavailability, meaning just a third of the active ingredients reached the bloodstream and tissues. However, with modern formulation research, this bioavailability has increased to approximately 60-70%, with only 30% of the product wasted. These advancements are driving remarkable improvements in product performance.
Additionally, the precise delivery systems enabled by these technologies ensure that active ingredients are more effectively absorbed by the body, leading to better consumer outcomes. The increased efficacy of these products reflects the ongoing innovation in the industry, which continuously strives to meet consumer demands for higher-quality and more effective solutions.
Q: What are the latest innovations and trends in the cosmetics and nutraceuticals industries?
A: Over the past decade, there has been considerable research on phytochemical molecules such as vitamin E, vitamin E drops, and skin toners incorporating quercetin, especially within the cosmeceuticals field. These bioactive compounds, derived from plants, have undergone rigorous scrutiny to confirm their skincare benefits. Their efficacy has been well-established, shedding light on their precise mechanisms and roles in enhancing skin health. This scientific validation has spurred industries to harness these insights, driving the development of innovative skincare products. As a result, these research findings have not only advanced scientific understanding but also catalyzed practical applications in the market, meeting consumer demands for effective and safe skincare solutions.
Q: How significantly will these products benefit individuals with critical illnesses?
A: Previously, Ayurveda relied solely on traditional knowledge without the validation of human trials. It was assumed that since these practices were rooted in ancient Vedas, no further validation was necessary. However, recent developments indicate a shift towards incorporating clinical trials to substantiate the efficacy of Ayurvedic treatments.
During discussions, it became evident that Ayurvedic products lacked established clinical evidence due to their historical basis in traditional practices. The assumption was that these remedies, passed down through generations, inherently possessed therapeutic benefits without formal scientific validation.
Today, there is a growing trend towards registering clinical trials for Ayurvedic therapies. This evolution is crucial as Ayurveda encompasses a holistic approach, integrating therapies, oral formulations, yoga, lifestyle adjustments, and dietary habits. While these aspects collectively form the treatment regimen, their efficacy requires validation through rigorous clinical trials, an area that warrants further attention.
Despite gaps in clinical validation, anecdotal evidence suggests Ayurveda’s potential to benefit various conditions, including cases where documented evidence may be lacking, such as in cancer treatment. Advocates argue that Ayurveda’s comprehensive approach, blending traditional wisdom with modern scientific scrutiny, offers a promising path forward in healthcare. As more trials are registered and conducted, there is optimism that Ayurveda will gain broader acceptance and recognition for its therapeutic efficacy across diverse medical conditions, bolstered by emerging data and patient testimonials.
In conclusion, while Ayurveda’s journey towards clinical validation is ongoing, its integrative nature and historical roots continue to intrigue and hold promise for the future of medical treatments.
